Skip to main content
SpringerLink
Log in

Long Term Follow Up of Adults with Congenital Heart Disease

  • Living reference work entry
  • First Online:
Pediatric Cardiology

  • 27 Accesses

Abstract

Survival for individuals with congenital heart disease (CHD) has greatly improved over the past several decades. There are now more adults than children with CHD. However, while survival has improved to adulthood, mortality in patients with CHD has shifted to adulthood. There is also significant morbidity in residual cardiac and noncardiac conditions. Additionally, acquired cardiovascular disease is a remaining issue as they reach elder years. This chapter will focus on the long-term issues that these individuals face in adulthood. Lifelong follow-up is imperative in order to improve the long-term outcome and quality of life of this vulnerable patient population.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Boneva RS, Botto LD, Moore CA, Yang Q, Correa A, Erickson JD. Mortality associated with congenital heart defects in the United States: trends and racial disparities, 1979–1997. Circulation. 2001;103(19):2376–81.

    Article  CAS  PubMed  Google Scholar 

  2. Stout KK, Daniels CJ, Aboulhosn JA, Bozkurt B, Broberg CS, Colman JM, et al. 2018 AHA/ACC guideline for the Management of Adults with Congenital Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;73(12):e81–e192.

    Article  PubMed  Google Scholar 

  3. van der Linde D, Konings EE, Slager MA, Witsenburg M, Helbing WA, Takkenberg JJ, et al. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol. 2011;58(21):2241–7.

    Article  PubMed  Google Scholar 

  4. Reller MD, Strickland MJ, Riehle-Colarusso T, Mahle WT, Correa A. Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005. J Pediatr. 2008;153(6):807–13.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Khairy P, Ionescu-Ittu R, Mackie AS, Abrahamowicz M, Pilote L, Marelli AJ. Changing mortality in congenital heart disease. J Am Coll Cardiol. 2010;56(14):1149–57.

    Article  PubMed  Google Scholar 

  6. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39(12):1890–900.

    Article  PubMed  Google Scholar 

  7. Warnes CA, Liberthson R, Danielson GK, Dore A, Harris L, Hoffman JI, et al. Task force 1: the changing profile of congenital heart disease in adult life. J Am Coll Cardiol. 2001;37(5):1170–5.

    Article  CAS  PubMed  Google Scholar 

  8. Marelli AJ, Ionescu-Ittu R, Mackie AS, Guo L, Dendukuri N, Kaouache M. Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010. Circulation. 2014;130(9):749–56.

    Article  PubMed  Google Scholar 

  9. Marelli AJ, Mackie AS, Ionescu-Ittu R, Rahme E, Pilote L. Congenital heart disease in the general population: changing prevalence and age distribution. Circulation. 2007;115(2):163–72.

    Article  PubMed  Google Scholar 

  10. Gilboa SM, Devine OJ, Kucik JE, Oster ME, Riehle-Colarusso T, Nembhard WN, et al. Congenital heart defects in the United States: estimating the magnitude of the affected population in 2010. Circulation. 2016;134(2):101–9.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Patel MS, Kogon BE. Care of the adult congenital heart disease patient in the United States: a summary of the current system. Pediatr Cardiol. 2010;31(4):511–4.

    Article  PubMed  Google Scholar 

  12. United States., United States. Congress. House. Office of the Legislative Counsel, United States. Congress. House. Committee on Ways and Means., United States. Congress. House. Committee on Energy and Commerce., United States. Congress. House. Committee on Education and Labor. Compilation of Patient Protection and Affordable Care Act: as amended through November 1, 2010 including Patient Protection and Affordable Care Act health-related portions of the Health Care and Education Reconciliation Act of 2010. Washington: U.S. Government Printing Office; 2010; xxiii, 955 p.

    Google Scholar 

  13. Lui GK, McGarry C, Bhatt A, Book W, Riehle-Colarusso TJ, Dunn JE, et al. Surveillance of congenital heart defects among adolescents at three U.S. Sites. Am J Cardiol. 2019;124(1):137–43.

    Article  PubMed  Google Scholar 

  14. Glidewell JBW, Raskind-Hood C, Hogue C, Dunn J, Gurvitz M, Ozonoff A, McGarry C, Van Zutphen A, Lui G, Downing K, Riehle-Colarusso T. Population-based surveillance of congenital heart defects among adolescents and adults: surveillance methodology. Birth Defects Res A Clin Mol Teratol. 2018;110:1–9.

    Google Scholar 

  15. Gurvitz M, Dunn JE, Bhatt A, Book WM, Glidewell J, Hogue C, et al. Characteristics of adults with congenital heart defects in the United States. J Am Coll Cardiol. 2020;76(2):175–82.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Gurvitz M, Valente AM, Broberg C, Cook S, Stout K, Kay J, et al. Prevalence and predictors of gaps in care among adult congenital heart disease patients: HEART-ACHD (The Health, Education, and Access Research Trial). J Am Coll Cardiol. 2013;61(21):2180–4.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Mackie AS, Ionescu-Ittu R, Therrien J, Pilote L, Abrahamowicz M, Marelli AJ. Children and adults with congenital heart disease lost to follow-up: who and when? Circulation. 2009;120(4):302–9.

    Article  PubMed  Google Scholar 

  18. Mackie AS, Pilote L, Ionescu-Ittu R, Rahme E, Marelli AJ. Health care resource utilization in adults with congenital heart disease. Am J Cardiol. 2007;99(6):839–43.

    Article  PubMed  Google Scholar 

  19. Opotowsky AR, Siddiqi OK, D’Souza B, Webb GD, Fernandes SM, Landzberg MJ. Maternal cardiovascular events during childbirth among women with congenital heart disease. Heart. 2012;98(2):145–51.

    Article  PubMed  Google Scholar 

  20. Schlichting LE, Insaf TZ, Zaidi AN, Lui GK, Van Zutphen AR. Maternal comorbidities and complications of delivery in pregnant women with congenital heart disease. J Am Coll Cardiol. 2019;73(17):2181–91.

    Article  PubMed  Google Scholar 

  21. Mylotte D, Pilote L, Ionescu-Ittu R, Abrahamowicz M, Khairy P, Therrien J, et al. Specialized adult congenital heart disease care: the impact of policy on mortality. Circulation. 2014;129(18):1804–12.

    Article  PubMed  Google Scholar 

  22. Lu Y, Agrawal G, Lin CW, Williams RG. Inpatient admissions and costs of congenital heart disease from adolescence to young adulthood. Am Heart J. 2014;168(6):948–55.

    Article  PubMed  Google Scholar 

  23. Islam S, Yasui Y, Kaul P, Marelli AJ, Mackie AS. Congenital heart disease hospitalizations in Canada: a 10-year experience. Can J Cardiol. 2016;32(2):197–203.

    Article  PubMed  Google Scholar 

  24. Wray J, Frigiola A, Bull C, Adult Congenital Heart disease Research N. Loss to specialist follow-up in congenital heart disease; out of sight, out of mind. Heart. 2013;99(7):485–90.

    Article  PubMed  Google Scholar 

  25. Norozi K, Wessel A, Alpers V, Arnhold JO, Geyer S, Zoege M, et al. Incidence and risk distribution of heart failure in adolescents and adults with congenital heart disease after cardiac surgery. Am J Cardiol. 2006;97(8):1238–43.

    Article  PubMed  Google Scholar 

  26. Opotowsky AR, Siddiqi OK, Webb GD. Trends in hospitalizations for adults with congenital heart disease in the U.S. J Am Coll Cardiol. 2009;54(5):460–7.

    Article  PubMed  Google Scholar 

  27. Vaikunth SS, Lui GK. Heart failure with reduced and preserved ejection fraction in adult congenital heart disease. Heart Fail Rev. 2019;25(4):569–81.

    Article  Google Scholar 

  28. Zomer AC, Verheugt CL, Vaartjes I, Uiterwaal CS, Langemeijer MM, Koolbergen DR, et al. Surgery in adults with congenital heart disease. Circulation. 2011;124(20):2195–201.

    Article  CAS  PubMed  Google Scholar 

  29. Nieminen HP, Jokinen EV, Sairanen HI. Causes of late deaths after pediatric cardiac surgery: a population-based study. J Am Coll Cardiol. 2007;50(13):1263–71.

    Article  PubMed  Google Scholar 

  30. Oechslin EN, Harrison DA, Connelly MS, Webb GD, Siu SC. Mode of death in adults with congenital heart disease. Am J Cardiol. 2000;86(10):1111–6.

    Article  CAS  PubMed  Google Scholar 

  31. Silka MJ, Hardy BG, Menashe VD, Morris CD. A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects. J Am Coll Cardiol. 1998;32(1):245–51.

    Article  CAS  PubMed  Google Scholar 

  32. Verheugt CL, Uiterwaal CS, van der Velde ET, Meijboom FJ, Pieper PG, van Dijk AP, et al. Mortality in adult congenital heart disease. Eur Heart J. 2010;31(10):1220–9.

    Article  PubMed  Google Scholar 

  33. Kaemmerer H, Fratz S, Bauer U, Oechslin E, Brodherr-Heberlein S, Zrenner B, et al. Emergency hospital admissions and three-year survival of adults with and without cardiovascular surgery for congenital cardiac disease. J Thorac Cardiovasc Surg. 2003;126(4):1048–52.

    Article  PubMed  Google Scholar 

  34. Khairy P, Van Hare GF, Balaji S, Berul CI, Cecchin F, Cohen MI, et al. PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD). Heart Rhythm. 2014;11(10):e102-65.

    PubMed  Google Scholar 

  35. Silka MJ, Bar-Cohen Y. A contemporary assessment of the risk for sudden cardiac death in patients with congenital heart disease. Pediatr Cardiol. 2012;33(3):452–60.

    Article  PubMed  Google Scholar 

  36. Hoffmann A, Chockalingam P, Balint OH, Dadashev A, Dimopoulos K, Engel R, et al. Cerebrovascular accidents in adult patients with congenital heart disease. Heart. 2010;96(15):1223–6.

    Article  CAS  PubMed  Google Scholar 

  37. Berglund E, Johansson B, Dellborg M, Sorensson P, Christersson C, Nielsen NE, et al. High incidence of infective endocarditis in adults with congenital ventricular septal defect. Heart. 2016;102(22):1835–9.

    Article  PubMed  Google Scholar 

  38. Mylotte D, Rushani D, Therrien J, Guo L, Liu A, Guo K, et al. Incidence, predictors, and mortality of infective endocarditis in adults with congenital heart disease without prosthetic valves. Am J Cardiol. 2017;120(12):2278–83.

    Article  PubMed  Google Scholar 

  39. O’Leary JM, Siddiqi OK, de Ferranti S, Landzberg MJ, Opotowsky AR. The changing demographics of congenital heart disease hospitalizations in the United States, 1998 through 2010. JAMA. 2013;309(10):984–6.

    Article  PubMed  Google Scholar 

  40. Lui GK, Saidi A, Bhatt AB, Burchill LJ, Deen JF, Earing MG, et al. Diagnosis and Management of Noncardiac Complications in adults with congenital heart disease: a scientific statement from the American Heart Association. Circulation. 2017;136(20):e348–e92.

    Article  PubMed  Google Scholar 

  41. Maxwell BG, Wong JK, Kin C, Lobato RL. Perioperative outcomes of major noncardiac surgery in adults with congenital heart disease. Anesthesiology. 2013;119(4):762–9.

    Article  PubMed  Google Scholar 

  42. Diller GP, Kempny A, Alonso-Gonzalez R, Swan L, Uebing A, Li W, et al. Survival prospects and circumstances of death in contemporary adult congenital heart disease patients under follow-up at a large tertiary Centre. Circulation. 2015;132(22):2118–25.

    Article  PubMed  Google Scholar 

  43. DeMaso DR, Calderon J, Taylor GA, Holland JE, Stopp C, White MT, et al. Psychiatric disorders in adolescents with single ventricle congenital heart disease. Pediatrics. 2017;139(3):e20162241.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Holland JE, Cassidy AR, Stopp C, White MT, Bellinger DC, Rivkin MJ, et al. Psychiatric disorders and function in adolescents with tetralogy of Fallot. J Pediatr. 2017;187:165–73.

    Article  PubMed  Google Scholar 

  45. Lanz J, Brophy JM, Therrien J, Kaouache M, Guo L, Marelli AJ. Stroke in adults with congenital heart disease: incidence, cumulative risk, and predictors. Circulation. 2015;132(25):2385–94.

    Article  PubMed  Google Scholar 

  46. Bagge CN, Henderson VW, Laursen HB, Adelborg K, Olsen M, Madsen NL. Risk of dementia in adults with congenital heart disease: population-based cohort study. Circulation. 2018;137(18):1912–20.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Kovacs AH, Saidi AS, Kuhl EA, Sears SF, Silversides C, Harrison JL, et al. Depression and anxiety in adult congenital heart disease: predictors and prevalence. Int J Cardiol. 2009;137(2):158–64.

    Article  PubMed  Google Scholar 

  48. Afilalo J, Therrien J, Pilote L, Ionescu-Ittu R, Martucci G, Marelli AJ. Geriatric congenital heart disease: burden of disease and predictors of mortality. J Am Coll Cardiol. 2011;58(14):1509–15.

    Article  PubMed  Google Scholar 

  49. Roche SL, Silversides CK. Hypertension, obesity, and coronary artery disease in the survivors of congenital heart disease. Can J Cardiol. 2013;29(7):841–8.

    Article  PubMed  Google Scholar 

  50. Lui GK, Fernandes S, McElhinney DB. Management of cardiovascular risk factors in adults with congenital heart disease. J Am Heart Assoc. 2014;3(6):e001076.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Moons P, Van Deyk K, Dedroog D, Troost E, Budts W. Prevalence of cardiovascular risk factors in adults with congenital heart disease. Eur J Cardiovasc Prev Rehabil. 2006;13(4):612–6.

    Article  PubMed  Google Scholar 

  52. Campbell M. Natural history of atrial septal defect. Br Heart J. 1970;32(6):820–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. John Sutton MG, Tajik AJ, McGoon DC. Atrial septal defect in patients ages 60 years or older: operative results and long-term postoperative follow-up. Circulation. 1981;64(2):402–9.

    Article  CAS  PubMed  Google Scholar 

  54. Komar M, Przewlocki T, Olszowska M, Sobien B, Podolec P. The benefit of atrial septal defect closure in elderly patients. Clin Interv Aging. 2014;9:1101–7.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Nasrallah AT, Hall RJ, Garcia E, Leachman RD, Cooley DA. Surgical repair of atrial septal defect in patients over 60 years of age. Long-term results. Circulation. 1976;53(2):329–31.

    Article  CAS  PubMed  Google Scholar 

  56. Swan L, Varma C, Yip J, Warr M, Webb G, Benson L, et al. Transcatheter device closure of atrial septal defects in the elderly: technical considerations and short-term outcomes. Int J Cardiol. 2006;107(2):207–10.

    Article  CAS  PubMed  Google Scholar 

  57. Cuypers JA, Opic P, Menting ME, Utens EM, Witsenburg M, Helbing WA, et al. The unnatural history of an atrial septal defect: longitudinal 35 year follow up after surgical closure at young age. Heart. 2013;99(18):1346–52.

    Article  PubMed  Google Scholar 

  58. Nyboe C, Olsen MS, Nielsen-Kudsk JE, Hjortdal VE. Atrial fibrillation and stroke in adult patients with atrial septal defect and the long-term effect of closure. Heart. 2015;101(9):706–11.

    Article  CAS  PubMed  Google Scholar 

  59. Gatzoulis MA, Freeman MA, Siu SC, Webb GD, Harris L. Atrial arrhythmia after surgical closure of atrial septal defects in adults. N Engl J Med. 1999;340(11):839–46.

    Article  CAS  PubMed  Google Scholar 

  60. Silversides CK, Siu SC, McLaughlin PR, Haberer KL, Webb GD, Benson L, et al. Symptomatic atrial arrhythmias and transcatheter closure of atrial septal defects in adult patients. Heart. 2004;90(10):1194–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Kort HW, Balzer DT, Johnson MC. Resolution of right heart enlargement after closure of secundum atrial septal defect with transcatheter technique. J Am Coll Cardiol. 2001;38(5):1528–32.

    Article  CAS  PubMed  Google Scholar 

  62. Brochu MC, Baril JF, Dore A, Juneau M, De Guise P, Mercier LA. Improvement in exercise capacity in asymptomatic and mildly symptomatic adults after atrial septal defect percutaneous closure. Circulation. 2002;106(14):1821–6.

    Article  PubMed  Google Scholar 

  63. Giardini A, Donti A, Specchia S, Coutsoumbas G, Formigari R, Prandstraller D, et al. Recovery kinetics of oxygen uptake is prolonged in adults with an atrial septal defect and improves after transcatheter closure. Am Heart J. 2004;147(5):910–4.

    Article  PubMed  Google Scholar 

  64. Salehian O, Horlick E, Schwerzmann M, Haberer K, McLaughlin P, Siu SC, et al. Improvements in cardiac form and function after transcatheter closure of secundum atrial septal defects. J Am Coll Cardiol. 2005;45(4):499–504.

    Article  PubMed  Google Scholar 

  65. Schoen SP, Kittner T, Bohl S, Braun MU, Simonis G, Schmeisser A, et al. Transcatheter closure of atrial septal defects improves right ventricular volume, mass, function, pulmonary pressure, and functional class: a magnetic resonance imaging study. Heart. 2006;92(6):821–6.

    Article  CAS  PubMed  Google Scholar 

  66. Patel A, Lopez K, Banerjee A, Joseph A, Cao QL, Hijazi ZM. Transcatheter closure of atrial septal defects in adults > or =40 years of age: immediate and follow-up results. J Interv Cardiol. 2007;20(1):82–8.

    Article  PubMed  Google Scholar 

  67. Oster M, Bhatt AB, Zaragoza-Macias E, Dendukuri N, Marelli A. Interventional therapy versus medical therapy for Secundum atrial septal defect: a systematic review (part 2) for the 2018 AHA/ACC guideline for the Management of Adults with Congenital Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;73(12):1579–95.

    Article  PubMed  Google Scholar 

  68. Schubert S, Peters B, Abdul-Khaliq H, Nagdyman N, Lange PE, Ewert P. Left ventricular conditioning in the elderly patient to prevent congestive heart failure after transcatheter closure of atrial septal defect. Catheter Cardiovasc Interv. 2005;64(3):333–7.

    Article  CAS  PubMed  Google Scholar 

  69. Miranda WR, Hagler DJ, Reeder GS, Warnes CA, Connolly HM, Egbe AC, et al. Temporary balloon occlusion of atrial septal defects in suspected or documented left ventricular diastolic dysfunction: hemodynamic and clinical findings. Catheter Cardiovasc Interv. 2019;93(6):1069–75.

    Article  PubMed  Google Scholar 

  70. Cherian G, Uthaman CB, Durairaj M, Sukumar IP, Krishnaswami S, Jairaj PS, et al. Pulmonary hypertension in isolated secundum atrial septal defect: high frequency in young patients. Am Heart J. 1983;105(6):952–7.

    Article  CAS  PubMed  Google Scholar 

  71. Craig RJ, Selzer A. Natural history and prognosis of atrial septal defect. Circulation. 1968;37(5):805–15.

    Article  CAS  PubMed  Google Scholar 

  72. Steele PM, Fuster V, Cohen M, Ritter DG, McGoon DC. Isolated atrial septal defect with pulmonary vascular obstructive disease–long-term follow-up and prediction of outcome after surgical correction. Circulation. 1987;76(5):1037–42.

    Article  CAS  PubMed  Google Scholar 

  73. Balint OH, Samman A, Haberer K, Tobe L, McLaughlin P, Siu SC, et al. Outcomes in patients with pulmonary hypertension undergoing percutaneous atrial septal defect closure. Heart. 2008;94(9):1189–93.

    Article  CAS  PubMed  Google Scholar 

  74. de Lezo JS, Medina A, Romero M, Pan M, Segura J, Caballero E, et al. Effectiveness of percutaneous device occlusion for atrial septal defect in adult patients with pulmonary hypertension. Am Heart J. 2002;144(5):877–80.

    Article  PubMed  Google Scholar 

  75. Manes A, Palazzini M, Leci E, Bacchi Reggiani ML, Branzi A, Galie N. Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups. Eur Heart J. 2014;35(11):716–24.

    Article  PubMed  Google Scholar 

  76. Karonis T, Scognamiglio G, Babu-Narayan SV, Montanaro C, Uebing A, Diller GP, et al. Clinical course and potential complications of small ventricular septal defects in adulthood: late development of left ventricular dysfunction justifies lifelong care. Int J Cardiol. 2016;208:102–6.

    Article  PubMed  Google Scholar 

  77. Neumayer U, Stone S, Somerville J. Small ventricular septal defects in adults. Eur Heart J. 1998;19(10):1573–82.

    Article  CAS  PubMed  Google Scholar 

  78. Jablonsky G, Hilton JD, Liu PP, Morch JE, Druck MN, Bar-Shlomo BZ, et al. Rest and exercise ventricular function in adults with congenital ventricular septal defects. Am J Cardiol. 1983;51(2):293–8.

    Article  CAS  PubMed  Google Scholar 

  79. Hsu DT. Closure is not correction: late outcomes of ventricular septal defect surgery. J Am Coll Cardiol. 2015;65(18):1952–3.

    Article  PubMed  Google Scholar 

  80. Kidd L, Driscoll DJ, Gersony WM, Hayes CJ, Keane JF, O’Fallon WM, et al. Second natural history study of congenital heart defects. Results of treatment of patients with ventricular septal defects. Circulation. 1993;87(2 Suppl):I38–51.

    CAS  PubMed  Google Scholar 

  81. Menting ME, Cuypers JA, Opic P, Utens EM, Witsenburg M, van den Bosch AE, et al. The unnatural history of the ventricular septal defect: outcome up to 40 years after surgical closure. J Am Coll Cardiol. 2015;65(18):1941–51.

    Article  PubMed  Google Scholar 

  82. Kempny A, Hjortshoj CS, Gu H, Li W, Opotowsky AR, Landzberg MJ, et al. Predictors of death in contemporary adult patients with Eisenmenger syndrome: a multicenter study. Circulation. 2017;135(15):1432–40.

    Article  PubMed  Google Scholar 

  83. Perloff JK, Child JS, Aboulhosn J. Congenital heart disease in adults. 3rd ed. Philadelphia: Saunders/Elsevier; 2009. xii, 488 p

    Google Scholar 

  84. Ammash NM, Warnes CA. Ventricular septal defects in adults. Ann Intern Med. 2001;135(9):812–24.

    Article  CAS  PubMed  Google Scholar 

  85. Naguib MA, Dob DP, Gatzoulis MA. A functional understanding of moderate to complex congenital heart disease and the impact of pregnancy. Part II: tetralogy of Fallot, Eisenmenger’s syndrome and the Fontan operation. Int J Obstet Anesth. 2010;19(3):306–12.

    Article  CAS  PubMed  Google Scholar 

  86. Simonneau G, Barst RJ, Galie N, Naeije R, Rich S, Bourge RC, et al. Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med. 2002;165(6):800–4.

    Article  PubMed  Google Scholar 

  87. Fernandes SM, Newburger JW, Lang P, Pearson DD, Feinstein JA, Gauvreau K, et al. Usefulness of epoprostenol therapy in the severely ill adolescent/adult with Eisenmenger physiology. Am J Cardiol. 2003;91(5):632–5.

    Article  CAS  PubMed  Google Scholar 

  88. Barst RJ, Langleben D, Badesch D, Frost A, Lawrence EC, Shapiro S, et al. Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan. J Am Coll Cardiol. 2006;47(10):2049–56.

    Article  CAS  PubMed  Google Scholar 

  89. Galie N, Beghetti M, Gatzoulis MA, Granton J, Berger RM, Lauer A, et al. Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study. Circulation. 2006;114(1):48–54.

    Article  CAS  PubMed  Google Scholar 

  90. Mukhopadhyay S, Sharma M, Ramakrishnan S, Yusuf J, Gupta MD, Bhamri N, et al. Phosphodiesterase-5 inhibitor in Eisenmenger syndrome: a preliminary observational study. Circulation. 2006;114(17):1807–10.

    Article  CAS  PubMed  Google Scholar 

  91. D’Alto M, Vizza CD, Romeo E, Badagliacca R, Santoro G, Poscia R, et al. Long term effects of bosentan treatment in adult patients with pulmonary arterial hypertension related to congenital heart disease (Eisenmenger physiology): safety, tolerability, clinical, and haemodynamic effect. Heart. 2007;93(5):621–5.

    Article  PubMed  Google Scholar 

  92. Rosenzweig EB, Kerstein D, Barst RJ. Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects. Circulation. 1999;99(14):1858–65.

    Article  CAS  PubMed  Google Scholar 

  93. Dimopoulos K, Inuzuka R, Goletto S, Giannakoulas G, Swan L, Wort SJ, et al. Improved survival among patients with Eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension. Circulation. 2010;121(1):20–5.

    Article  PubMed  Google Scholar 

  94. Brown ML, Dearani JA, Danielson GK, Cetta F, Connolly HM, Warnes CA, et al. The outcomes of operations for 539 patients with Ebstein anomaly. J Thorac Cardiovasc Surg. 2008;135(5):1120–236, 36 e1-7

    Article  PubMed  Google Scholar 

  95. Yesin M, Kalcik M. Ebstein anomaly in an asymptomatic nonagenarian: a case report. Curr Res Cardiology. 2016;2(1) https://doi.org/10.4172/2368-0512.1000027.

  96. Attie F, Rosas M, Rijlaarsdam M, Buendia A, Zabal C, Kuri J, et al. The adult patient with Ebstein anomaly. Outcome in 72 unoperated patients. Medicine. 2000;79(1):27–36.

    Article  CAS  PubMed  Google Scholar 

  97. Attenhofer Jost CH, Connolly HM, Scott CG, Burkhart HM, Ammash NM, Dearani JA. Increased risk of possible paradoxical embolic events in adults with ebstein anomaly and severe tricuspid regurgitation. Congenit Heart Dis. 2014;9(1):30–7.

    Article  PubMed  Google Scholar 

  98. Tan NY, Attenhofer Jost CH, Polkinghorne MD, Vargas ER, Hodge DO, Dearani JA, et al. Cerebrovascular accidents in Ebstein’s anomaly. Congenit Heart Dis. 2019;14(6):1157–65.

    Article  PubMed  Google Scholar 

  99. Celermajer DS, Bull C, Till JA, Cullen S, Vassillikos VP, Sullivan ID, et al. Ebstein’s anomaly: presentation and outcome from fetus to adult. J Am Coll Cardiol. 1994;23(1):170–6.

    Article  CAS  PubMed  Google Scholar 

  100. Brown ML, Dearani JA, Danielson GK, Cetta F, Connolly HM, Warnes CA, Li Z, Hodge DO, Driscoll DJ, et al. Functional status after operation for Ebstein anomaly. J Am Coll Cardiol. 2008;52(6):460–6.

    Article  PubMed  Google Scholar 

  101. Pediatric, Congenital Electrophysiology S, Heart Rhythm S, American College of Cardiology F, American Heart A, American Academy of P, et al. PACES/HRS expert consensus statement on the management of the asymptomatic young patient with a Wolff-Parkinson-White (WPW, ventricular preexcitation) electrocardiographic pattern: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology Foundation (ACCF), the American Heart Association (AHA), the American Academy of Pediatrics (AAP), and the Canadian Heart Rhythm Society (CHRS). Heart Rhythm. 2012;9(6):1006-24.

    Google Scholar 

  102. Attenhofer Jost CH, Tan NY, Hassan A, Vargas ER, Hodge DO, Dearani JA, et al. Sudden death in patients with Ebstein anomaly. Eur Heart J. 2018;39(21):1970–a.

    Article  PubMed  Google Scholar 

  103. Gurvitz M, Stout K. Ebstein’s anomaly of the tricuspid valve. Curr Cardiol Rep. 2007;9(4):336–42.

    Article  PubMed  Google Scholar 

  104. Silva M, Teixeira A, Menezes I, Nogueira G, Ferreira R, Maymone-Martins F, et al. Percutaneous closure of atrial right-to-left shunt in patients with Ebstein’s anomaly of the tricuspid valve. EuroIntervention. 2012;8(1):94–7.

    Article  PubMed  Google Scholar 

  105. Jategaonkar SR, Scholtz W, Horstkotte D, Kececioglu D, Haas NA. Interventional closure of atrial septal defects in adult patients with Ebstein’s anomaly. Congenit Heart Dis. 2011;6(4):374–81.

    Article  PubMed  Google Scholar 

  106. Attenhofer Jost CH, Connolly HM, Scott CG, Burkhart HM, Warnes CA, Dearani JA. Outcome of cardiac surgery in patients 50 years of age or older with Ebstein anomaly: survival and functional improvement. J Am Coll Cardiol. 2012;59(23):2101–6.

    Article  PubMed  Google Scholar 

  107. Holst KA, Dearani JA, Said S, Pike RB, Connolly HM, Cannon BC, et al. Improving results of surgery for Ebstein anomaly: where are we after 235 cone repairs? Ann Thorac Surg. 2018;105(1):160–8.

    Article  PubMed  Google Scholar 

  108. Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration with the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;52(23):e143–263.

    Article  PubMed  Google Scholar 

  109. Taggart NW, Cabalka AK, Eicken A, Aboulhosn JA, Thomson JDR, Whisenant B, et al. Outcomes of Transcatheter tricuspid valve-in-valve implantation in patients with Ebstein anomaly. Am J Cardiol. 2018;121(2):262–8.

    Article  PubMed  Google Scholar 

  110. Roten L, Lukac P, de Groot N, Nielsen JC, Szili-Torok T, Jensen HK, et al. Catheter ablation of arrhythmias in ebstein’s anomaly: a multicenter study. J Cardiovasc Electrophysiol. 2011;22(12):1391–6.

    Article  PubMed  Google Scholar 

  111. Siu SC, Silversides CK. Bicuspid aortic valve disease. J Am Coll Cardiol. 2010;55(25):2789–800.

    Article  PubMed  Google Scholar 

  112. Fernandes SM, Sanders SP, Khairy P, Jenkins KJ, Gauvreau K, Lang P, et al. Morphology of bicuspid aortic valve in children and adolescents. J Am Coll Cardiol. 2004;44(8):1648–51.

    Article  PubMed  Google Scholar 

  113. Sievers HH, Schmidtke C. A classification system for the bicuspid aortic valve from 304 surgical specimens. J Thorac Cardiovasc Surg. 2007;133(5):1226–33.

    Article  PubMed  Google Scholar 

  114. Roberts WC, Ko JM. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation. 2005;111(7):920–5.

    Article  PubMed  Google Scholar 

  115. Huntington K, Hunter AG, Chan KL. A prospective study to assess the frequency of familial clustering of congenital bicuspid aortic valve. J Am Coll Cardiol. 1997;30(7):1809–12.

    Article  CAS  PubMed  Google Scholar 

  116. Atkins SK, Sucosky P. Etiology of bicuspid aortic valve disease: focus on hemodynamics. World J Cardiol. 2014;6(12):1227–33.

    Article  PubMed  PubMed Central  Google Scholar 

  117. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg. 2014;148(1):e1–e132.

    Article  PubMed  Google Scholar 

  118. Tzemos N, Therrien J, Yip J, Thanassoulis G, Tremblay S, Jamorski MT, et al. Outcomes in adults with bicuspid aortic valves. JAMA. 2008;300(11):1317–25.

    Article  CAS  PubMed  Google Scholar 

  119. Michelena HI, Desjardins VA, Avierinos JF, Russo A, Nkomo VT, Sundt TM, et al. Natural history of asymptomatic patients with normally functioning or minimally dysfunctional bicuspid aortic valve in the community. Circulation. 2008;117(21):2776–84.

    Article  PubMed  PubMed Central  Google Scholar 

  120. Biner S, Rafique AM, Ray I, Cuk O, Siegel RJ, Tolstrup K. Aortopathy is prevalent in relatives of bicuspid aortic valve patients. J Am Coll Cardiol. 2009;53(24):2288–95.

    Article  PubMed  PubMed Central  Google Scholar 

  121. Silberbach M, Roos-Hesselink JW, Andersen NH, Braverman AC, Brown N, Collins RT, et al. Cardiovascular health in Turner syndrome: a scientific statement from the American Heart Association. Circ Genom Precis Med. 2018;11(10):e000048.

    Article  PubMed  Google Scholar 

  122. Michelena HI, Prakash SK, Della Corte A, Bissell MM, Anavekar N, Mathieu P, et al. Bicuspid aortic valve: identifying knowledge gaps and rising to the challenge from the International Bicuspid Aortic Valve Consortium (BAVCon). Circulation. 2014;129(25):2691–704.

    Article  PubMed  PubMed Central  Google Scholar 

  123. Masri A, Kalahasti V, Alkharabsheh S, Svensson LG, Sabik JF, Roselli EE, et al. Characteristics and long-term outcomes of contemporary patients with bicuspid aortic valves. J Thorac Cardiovasc Surg. 2016;151(6):1650–9 e1.

    Article  PubMed  Google Scholar 

  124. Mazine A, Rocha RV, El-Hamamsy I, Ouzounian M, Yanagawa B, Bhatt DL, et al. Ross procedure vs mechanical aortic valve replacement in adults: a systematic review and meta-analysis. JAMA Cardiol. 2018;3(10):978–87.

    Article  PubMed  PubMed Central  Google Scholar 

  125. Halim SA, Edwards FH, Dai D, Li Z, Mack MJ, Holmes DR, et al. Outcomes of Transcatheter aortic valve replacement in patients with bicuspid aortic valve disease: a report from the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. Circulation. 2020;141(13):1071–9.

    Article  PubMed  Google Scholar 

  126. Yoon S-H, Kim W-K, Dhoble A, Milhorini Pio S, Babaliaros V, Jilaihawi H, et al. Bicuspid aortic valve morphology and outcomes after Transcatheter aortic valve replacement. J Am Coll Cardiol. 2020;76(9):1018–30.

    Article  CAS  PubMed  Google Scholar 

  127. Braverman AC, Harris KM, Kovacs RJ, Maron BJ. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 7: aortic diseases, including Marfan syndrome: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015;66(21):2398–405.

    Article  PubMed  Google Scholar 

  128. Brown ML, Burkhart HM, Connolly HM, Dearani JA, Cetta F, Li Z, et al. Coarctation of the aorta: lifelong surveillance is mandatory following surgical repair. J Am Coll Cardiol. 2013;62(11):1020–5.

    Article  PubMed  Google Scholar 

  129. Cohen M, Fuster V, Steele PM, Driscoll D, McGoon DC. Coarctation of the aorta. Long-term follow-up and prediction of outcome after surgical correction. Circulation. 1989;80(4):840–5.

    Article  CAS  PubMed  Google Scholar 

  130. Hager A, Kanz S, Kaemmerer H, Schreiber C, Hess J. Coarctation Long-term Assessment (COALA): significance of arterial hypertension in a cohort of 404 patients up to 27 years after surgical repair of isolated coarctation of the aorta, even in the absence of restenosis and prosthetic material. J Thorac Cardiovasc Surg. 2007;134(3):738–45.

    Article  PubMed  Google Scholar 

  131. Seirafi PA, Warner KG, Geggel RL, Payne DD, Cleveland RJ. Repair of coarctation of the aorta during infancy minimizes the risk of late hypertension. Ann Thorac Surg. 1998;66(4):1378–82.

    Article  CAS  PubMed  Google Scholar 

  132. Morgan GJ, Lee KJ, Chaturvedi R, Bradley TJ, Mertens L, Benson L. Systemic blood pressure after stent management for arch coarctation implications for clinical care. JACC Cardiovasc Interv. 2013;6(2):192–201.

    Article  PubMed  Google Scholar 

  133. Group SR, Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373(22):2103–16.

    Article  Google Scholar 

  134. Brili S, Tousoulis D, Antoniades C, Vasiliadou C, Karali M, Papageorgiou N, et al. Effects of ramipril on endothelial function and the expression of proinflammatory cytokines and adhesion molecules in young normotensive subjects with successfully repaired coarctation of aorta: a randomized cross-over study. J Am Coll Cardiol. 2008;51(7):742–9.

    Article  CAS  PubMed  Google Scholar 

  135. Giordano U, Cifra B, Giannico S, Turchetta A, Calzolari A. Mid-term results, and therapeutic management, for patients suffering hypertension after surgical repair of aortic coarctation. Cardiol Young. 2009;19(5):451–5.

    Article  PubMed  Google Scholar 

  136. Moltzer E, Mattace Raso FU, Karamermer Y, Boersma E, Webb GD, Simoons ML, et al. Comparison of Candesartan versus Metoprolol for treatment of systemic hypertension after repaired aortic coarctation. Am J Cardiol. 2010;105(2):217–22.

    Article  CAS  PubMed  Google Scholar 

  137. Luijendijk P, Bouma BJ, Vriend JW, Vliegen HW, Groenink M, Mulder BJ. Usefulness of exercise-induced hypertension as predictor of chronic hypertension in adults after operative therapy for aortic isthmic coarctation in childhood. Am J Cardiol. 2011;108(3):435–9.

    Article  PubMed  Google Scholar 

  138. Pickard SS, Gauvreau K, Gurvitz M, Gagne JJ, Opotowsky AR, Jenkins KJ, et al. Stroke in adults with coarctation of the aorta: a national population-based study. J Am Heart Assoc. 2018;7(11):e009072.

    Article  PubMed  PubMed Central  Google Scholar 

  139. Roifman I, Therrien J, Ionescu-Ittu R, Pilote L, Guo L, Kotowycz MA, et al. Coarctation of the aorta and coronary artery disease: fact or fiction? Circulation. 2012;126(1):16–21.

    Article  PubMed  Google Scholar 

  140. de Divitiis M, Pilla C, Kattenhorn M, Zadinello M, Donald A, Leeson P, et al. Vascular dysfunction after repair of coarctation of the aorta: impact of early surgery. Circulation. 2001;104(12 Suppl 1):I165–70.

    Article  PubMed  Google Scholar 

  141. Mizia-Stec K, Trojnarska O, Szczepaniak-Chichel L, Gabriel M, Bartczak A, Cieplucha A, et al. Asymmetric dimethylarginine and vascular indices of atherosclerosis in patients after coarctation of aorta repair. Int J Cardiol. 2012;158(3):364–9.

    Article  PubMed  Google Scholar 

  142. Heger M, Willfort A, Neunteufl T, Rosenhek R, Gabriel H, Wollenek G, et al. Vascular dysfunction after coarctation repair is related to the age at surgery. Int J Cardiol. 2005;99(2):295–9.

    Article  PubMed  Google Scholar 

  143. Luijendijk P, Lu H, Heynneman FB, Huijgen R, de Groot EE, Vriend JW, et al. Increased carotid intima-media thickness predicts cardiovascular events in aortic coarctation. Int J Cardiol. 2014;176(3):776–81.

    Article  PubMed  Google Scholar 

  144. Luijendijk P, Bouma BJ, Vriend JW, Groenink M, Vliegen HW, de Groot E, et al. Beneficial effect of high dose statins on the vascular wall in patients with repaired aortic coarctation? Int J Cardiol. 2014;176(1):40–7.

    Article  CAS  PubMed  Google Scholar 

  145. Brili S, Tousoulis D, Antonopoulos AS, Antoniades C, Hatzis G, Bakogiannis C, et al. Effects of atorvastatin on endothelial function and the expression of proinflammatory cytokines and adhesion molecules in young subjects with successfully repaired coarctation of aorta. Heart. 2012;98(4):325–9.

    Article  CAS  PubMed  Google Scholar 

  146. Chen SS, Dimopoulos K, Alonso-Gonzalez R, Liodakis E, Teijeira-Fernandez E, Alvarez-Barredo M, et al. Prevalence and prognostic implication of restenosis or dilatation at the aortic coarctation repair site assessed by cardiovascular MRI in adult patients late after coarctation repair. Int J Cardiol. 2014;173(2):209–15.

    Article  CAS  PubMed  Google Scholar 

  147. Parks WJ, Ngo TD, Plauth WH Jr, Bank ER, Sheppard SK, Pettigrew RI, et al. Incidence of aneurysm formation after Dacron patch aortoplasty repair for coarctation of the aorta: long-term results and assessment utilizing magnetic resonance angiography with three-dimensional surface rendering. J Am Coll Cardiol. 1995;26(1):266–71.

    Article  CAS  PubMed  Google Scholar 

  148. Sachdeva R, Valente AM, Armstrong AK, Cook SC, Han BK, Lopez L, et al. ACC/AHA/ASE/HRS/ISACHD/SCAI/SCCT/SCMR/SOPE 2020 Appropriate Use Criteria for Multimodality Imaging During the Follow-Up Care of Patients With Congenital Heart Disease: A Report of the American College of Cardiology Solution Set Oversight Committee and Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Pediatric Echocardiography. J Am Coll Cardiol. 2020;75(6):657–703.

    Article  PubMed  Google Scholar 

  149. Liebman J, Cullum L, Belloc NB. Natural history of transpositon of the great arteries. Anatomy and birth and death characteristics. Circulation. 1969;40(2):237–62.

    Article  CAS  PubMed  Google Scholar 

  150. Mustard WT. Successful two-stage correction of transposition of the great vessels. Surgery. 1964;55:469–72.

    CAS  PubMed  Google Scholar 

  151. Senning A. Surgical correction of transposition of the great vessels. Surgery. 1959;45(6):966–80.

    CAS  PubMed  Google Scholar 

  152. Jatene AD, Fontes VF, Paulista PP, Souza LC, Neger F, Galantier M, et al. Anatomic correction of transposition of the great vessels. J Thorac Cardiovasc Surg. 1976;72(3):364–70.

    Article  CAS  PubMed  Google Scholar 

  153. Konstantinov IE, Alexi-Meskishvili VV, Williams WG, Freedom RM, Van Praagh R. Atrial switch operation: past, present, and future. Ann Thorac Surg. 2004;77(6):2250–8.

    Article  PubMed  Google Scholar 

  154. Hörer J, Schreiber C, Cleuziou J, Vogt M, Prodan Z, Busch R, et al. Improvement in long-term survival after hospital discharge but not in freedom from reoperation after the change from atrial to arterial switch for transposition of the great arteries. J Thorac Cardiovasc Surg. 2009;137(2):347–54.

    Article  PubMed  Google Scholar 

  155. Rastelli GC, McGoon DC, Wallace RB. Anatomic correction of transposition of the great arteries with ventricular septal defect and subpulmonary stenosis. J Thorac Cardiovasc Surg. 1969;58(4):545–52.

    Article  CAS  PubMed  Google Scholar 

  156. Cuypers JA, Eindhoven JA, Slager MA, Opic P, Utens EM, Helbing WA, et al. The natural and unnatural history of the Mustard procedure: long-term outcome up to 40 years. Eur Heart J. 2014;35(25):1666–74.

    Article  PubMed  Google Scholar 

  157. Sarkar D, Bull C, Yates R, Wright D, Cullen S, Gewillig M, et al. Comparison of long-term outcomes of atrial repair of simple transposition with implications for a late arterial switch strategy. Circulation. 1999;100(Supplement 2):II-176-II-81.

    Article  Google Scholar 

  158. Roos-Hesselink JW, Meijboom FJ, Spitaels SE, van Domburg R, van Rijen EH, Utens EM, et al. Decline in ventricular function and clinical condition after Mustard repair for transposition of the great arteries (a prospective study of 22-29 years). Eur Heart J. 2004;25(14):1264–70.

    Article  CAS  PubMed  Google Scholar 

  159. Giardini A, Khambadkone S, Taylor A, Derrick G. Effect of abnormal pulmonary flow distribution on ventilatory efficiency and exercise capacity after arterial switch operation for transposition of great arteries. Am J Cardiol. 2010;106(7):1023–8.

    Article  PubMed  Google Scholar 

  160. Vejlstrup N, Sørensen K, Mattsson E, Thilén U, Kvidal P, Johansson B, et al. Long-term outcome of Mustard/Senning correction for transposition of the great arteries in Sweden and Denmark. Circulation. 2015;132(8):633–8.

    Article  PubMed  Google Scholar 

  161. Zaragoza-Macias E, Zaidi AN, Dendukuri N, Marelli A. Medical therapy for systemic right ventricles: a systematic review (part 1) for the 2018 AHA/ACC guideline for the Management of Adults with Congenital Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139(14):e801–e13.

    Article  PubMed  Google Scholar 

  162. Doughan AR, McConnell ME, Book WM. Effect of beta blockers (carvedilol or metoprolol XL) in patients with transposition of great arteries and dysfunction of the systemic right ventricle. Am J Cardiol. 2007;99(5):704–6.

    Article  CAS  PubMed  Google Scholar 

  163. Lester SJ, McElhinney DB, Viloria E, Reddy GP, Ryan E, Tworetzky W, et al. Effects of losartan in patients with a systemically functioning morphologic right ventricle after atrial repair of transposition of the great arteries. Am J Cardiol. 2001;88(11):1314–6.

    Article  CAS  PubMed  Google Scholar 

  164. Gelatt M, Hamilton RM, McCrindle BW, Connelly M, Davis A, Harris L, et al. Arrhythmia and mortality after the Mustard procedure: a 30-year single-center experience. J Am Coll Cardiol. 1997;29(1):194–201.

    Article  CAS  PubMed  Google Scholar 

  165. Love BA, Mehta D, Fuster VF. Evaluation and management of the adult patient with transposition of the great arteries following atrial-level (Senning or Mustard) repair. Nat Clin Pract Cardiovasc Med. 2008;5(8):454–67.

    Article  PubMed  Google Scholar 

  166. Khairy P, Harris L, Landzberg MJ, Fernandes SM, Barlow A, Mercier LA, et al. Sudden death and defibrillators in transposition of the great arteries with intra-atrial baffles: a multicenter study. Circ Arrhythm Electrophysiol. 2008;1(4):250–7.

    Article  PubMed  Google Scholar 

  167. Kammeraad JA, van Deurzen CH, Sreeram N, Bink-Boelkens MT, Ottenkamp J, Helbing WA, et al. Predictors of sudden cardiac death after Mustard or Senning repair for transposition of the great arteries. J Am Coll Cardiol. 2004;44(5):1095–102.

    Article  PubMed  Google Scholar 

  168. Chakrabarti S, Stuart AG. Terminal arrhythmia in a patient with Mustard’s operation. Cardiol Young. 2006;16(5):498–500.

    Article  PubMed  Google Scholar 

  169. Backhoff D, Kerst G, Peters A, Lüdemann M, Frische C, Horndasch M, et al. Internal cardioverter defibrillator indications and therapies after atrial baffle procedure for d-transposition of the great arteries: a Multicenter analysis. Pacing Clin Electrophysiol. 2016;39(10):1070–6.

    Article  PubMed  Google Scholar 

  170. Jonathan Buber J, Ackley T, Daniels CJ, Roble SL, Ling Mah M, Kamp AN, et al. Outcomes following the implantation of cardioverter-defibrillator for primary prevention in transposition of the great arteries after intra-atrial baffle repair: a single-Centre experience. Europace. 2016;18(7):1016–22.

    Article  PubMed  Google Scholar 

  171. Pasquale Gabriella D, Tempesta Francesca B, Santos Lopes B, Babic D, Oxenius A, Seeliger T, et al. High prevalence of baffle leaks in adults after atrial switch operations for transposition of the great arteries. Eur Heart J Cardiovasc Imaging. 2017;18:jew276.

    Article  Google Scholar 

  172. Bottega NA, Silversides CK, Oechslin EN, Dissanayake K, Harrison JL, Provost Y, et al. Stenosis of the superior limb of the systemic venous baffle following a Mustard procedure: an under-recognized problem. Int J Cardiol. 2012;154(1):32–7.

    Article  PubMed  Google Scholar 

  173. Paul Khairy J, Landzberg M, Gatzoulis MA, Lise-AndréE Mercier M, Fernandes S, Jean-Marc CôTé, et al. Transvenous pacing leads and systemic Thromboemboli in patients with Intracardiac shunts. Circulation. 2006;113(20):2391–7.

    Article  PubMed  Google Scholar 

  174. Scherptong RW, Vliegen HW, Winter MM, Holman ER, Mulder BJ, van der Wall EE, et al. Tricuspid valve surgery in adults with a dysfunctional systemic right ventricle: repair or replace? Circulation. 2009;119(11):1467–72.

    Article  PubMed  Google Scholar 

  175. Koolbergen DR, Ahmed Y, Bouma BJ, Scherptong RW, Bruggemans EF, Vliegen HW, et al. Follow-up after tricuspid valve surgery in adult patients with systemic right ventricles. Eur J Cardiothorac Surg. 2016;50(3):456–63.

    Article  PubMed  Google Scholar 

  176. Lim HG, Kim WH, Lee JR, Kim YJ. Long-term results of the arterial switch operation for ventriculo-arterial discordance. Eur J Cardiothorac Surg. 2013;43(2):325–34.

    Article  PubMed  Google Scholar 

  177. Losay J, Touchot A, Serraf A, Litvinova A, Lambert V, Piot JD, et al. Late outcome after arterial switch operation for transposition of the great arteries. Circulation. 2001;104(suppl 1):I-121-I-6.

    Article  Google Scholar 

  178. Bonnet D, Bonhoeffer P, Piechaud JF, Aggoun Y, Sidi D, Planche C, et al. Long-term fate of the coronary arteries after the arterial switch operation in newborns with transposition of the great arteries. Heart. 1996;76(3):274–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  179. Thrupp SF, Gentles TL, Kerr AR, Finucane K. Arterial switch operation: early and late outcome for intramural coronary arteries. Ann Thorac Surg. 2012;94(6):2084–90.

    Article  PubMed  Google Scholar 

  180. Kim H, Sung SC, Kim SH, Chang YH, Ahn HY, Lee HD. Arterial switch operation in patients with intramural coronary artery: early and mid-term results. Korean J Thorac Cardiovasc Surg. 2011;44(2):115–22.

    Article  PubMed  PubMed Central  Google Scholar 

  181. Hutter PA, Kreb DL, Mantel SF, Hitchcock JF, Meijboom EJ, Bennink GB. Twenty-five years’ experience with the arterial switch operation. J Thorac Cardiovasc Surg. 2002;124(4):790–7.

    Article  CAS  PubMed  Google Scholar 

  182. Khairy P, Clair M, Fernandes SM, Blume ED, Powell AJ, Newburger JW, et al. Cardiovascular outcomes after the arterial switch operation for D-transposition of the great arteries. Circulation. 2013;127(3):331–9.

    Article  PubMed  Google Scholar 

  183. Ma K, Li S, Hu S, Hua Z, Yang K, Yan J, et al. Neoaortic valve regurgitation after arterial switch: ten years outcomes from a single center. Ann Thorac Surg. 2016;102(2):636–42.

    Article  PubMed  Google Scholar 

  184. van der Palen RLF, van der Bom T, Dekker A, Tsonaka R, van Geloven N, Kuipers IM, et al. Progression of aortic root dilatation and aortic valve regurgitation after the arterial switch operation. Heart. 2019;105(22):1732–40.

    Article  PubMed  Google Scholar 

  185. Placci A, Lovato L, Bonvicini M. Congenitally corrected transposition of the great arteries in an 83-year-old asymptomatic patient: description and literature review. BMJ Case Rep. 2014;2014:bcr2014204228.

    Article  PubMed  PubMed Central  Google Scholar 

  186. Wissocque L, Mondesert B, Dubart AE. Late diagnosis of isolated congenitally corrected transposition of the great arteries in a 92-year old woman. Eur J Cardiothorac Surg. 2016;49(5):1524–5.

    Article  PubMed  Google Scholar 

  187. Connelly MS, Liu PP, Williams WG, Webb GD, Robertson P, McLaughlin PR. Congenitally corrected transposition of the great arteries in the adult: functional status and complications. J Am Coll Cardiol. 1996;27(5):1238–43.

    Article  CAS  PubMed  Google Scholar 

  188. Graham TP Jr, Bernard YD, Mellen BG, Celermajer D, Baumgartner H, Cetta F, et al. Long-term outcome in congenitally corrected transposition of the great arteries: a multi-institutional study. J Am Coll Cardiol. 2000;36(1):255–61.

    Article  PubMed  Google Scholar 

  189. Prieto LR, Hordof AJ, Secic M, Rosenbaum MS, Gersony WM. Progressive tricuspid valve disease in patients with congenitally corrected transposition of the great arteries. Circulation. 1998;98(10):997–1005.

    Article  CAS  PubMed  Google Scholar 

  190. Helsen F, De Meester P, Van Keer J, Gabriels C, Van De Bruaene A, Herijgers P, et al. Pulmonary outflow obstruction protects against heart failure in adults with congenitally corrected transposition of the great arteries. Int J Cardiol. 2015;196:1–6.

    Article  PubMed  Google Scholar 

  191. Warnes CA. Transposition of the great arteries. Circulation. 2006;114(24):2699–709.

    Article  PubMed  Google Scholar 

  192. Hofferberth SC, Alexander ME, Mah DY, Bautista-Hernandez V, del Nido PJ, Fynn-Thompson F. Impact of pacing on systemic ventricular function in L-transposition of the great arteries. J Thorac Cardiovasc Surg. 2016;151(1):131–8.

    Article  PubMed  Google Scholar 

  193. Dubin AM, Janousek J, Rhee E, Strieper MJ, Cecchin F, Law IH, et al. Resynchronization therapy in pediatric and congenital heart disease patients: an international multicenter study. J Am Coll Cardiol. 2005;46(12):2277–83.

    Article  PubMed  Google Scholar 

  194. Adachi O, Masaki N, Kawatsu S, Yoshioka I, Masuda S, Fujiwara H, et al. Long-term results after physiologic repair for congenitally corrected transposition of the great arteries. Gen Thorac Cardiovasc Surg. 2016;64(12):715–21.

    Article  PubMed  Google Scholar 

  195. Mongeon FP, Connolly HM, Dearani JA, Li Z, Warnes CA. Congenitally corrected transposition of the great arteries ventricular function at the time of systemic atrioventricular valve replacement predicts long-term ventricular function. J Am Coll Cardiol. 2011;57(20):2008–17.

    Article  PubMed  Google Scholar 

  196. Filippov AA, Del Nido PJ, Vasilyev NV. Management of Systemic Right Ventricular Failure in patients with congenitally corrected transposition of the great arteries. Circulation. 2016;134(17):1293–302.

    Article  PubMed  Google Scholar 

  197. Gaies MG, Goldberg CS, Ohye RG, Devaney EJ, Hirsch JC, Bove EL. Early and intermediate outcome after anatomic repair of congenitally corrected transposition of the great arteries. Ann Thorac Surg. 2009;88(6):1952–60.

    Article  PubMed  Google Scholar 

  198. Hraska V, Vergnat M, Zartner P, Hart C, Suchowerskyj P, Bierbach B, et al. Promising outcome of anatomic correction of corrected transposition of the great arteries. Ann Thorac Surg. 2017;104(2):650–6.

    Article  PubMed  Google Scholar 

  199. Ibrahimiye AN, Mainwaring RD, Patrick WL, Downey L, Yarlagadda V, Hanley FL. Left ventricular retraining and double switch in patients with congenitally corrected transposition of the great arteries. World J Pediatr Congenit Heart Surg. 2017;8(2):203–9.

    Article  PubMed  Google Scholar 

  200. Lillehei CW, Cohen M, Warden HE, Read RC, Aust JB, Dewall RA, et al. Direct vision intracardiac surgical correction of the tetralogy of Fallot, pentalogy of Fallot, and pulmonary atresia defects; report of first ten cases. Ann Surg. 1955;142(3):418–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  201. Bertranou EG, Blackstone EH, Hazelrig JB, Turner ME, Kirklin JW. Life expectancy without surgery in tetralogy of Fallot. Am J Cardiol. 1978;42(3):458–66.

    Article  CAS  PubMed  Google Scholar 

  202. Samanek M. Children with congenital heart disease: probability of natural survival. Pediatr Cardiol. 1992;13(3):152–8.

    Article  CAS  PubMed  Google Scholar 

  203. Smith CA, McCracken C, Thomas AS, Spector LG, St Louis JD, Oster ME, et al. Long-term outcomes of tetralogy of Fallot: a study from the Pediatric cardiac care consortium. JAMA Cardiol. 2019;4(1):34–41.

    Article  PubMed  Google Scholar 

  204. Dennis M, Moore B, Kotchetkova I, Pressley L, Cordina R, Celermajer DS. Adults with repaired tetralogy: low mortality but high morbidity up to middle age. Open Heart. 2017;4(1):e000564.

    Article  PubMed  PubMed Central  Google Scholar 

  205. van den Bosch E, Bogers A, Roos-Hesselink JW, van Dijk APJ, van Wijngaarden M, Boersma E, et al. Long-term follow-up after transatrial-transpulmonary repair of tetralogy of Fallot: influence of timing on outcome. Eur J Cardiothorac Surg. 2020;57(4):635–43.

    Article  PubMed  Google Scholar 

  206. Murphy JG, Gersh BJ, Mair DD, Fuster V, McGoon MD, Ilstrup DM, et al. Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot. N Engl J Med. 1993;329(9):593–9.

    Article  CAS  PubMed  Google Scholar 

  207. Nollert G, Fischlein T, Bouterwek S, Bohmer C, Klinner W, Reichart B. Long-term survival in patients with repair of tetralogy of Fallot: 36-year follow-up of 490 survivors of the first year after surgical repair. J Am Coll Cardiol. 1997;30(5):1374–83.

    Article  CAS  PubMed  Google Scholar 

  208. Burchill LJ, Gao L, Kovacs AH, Opotowsky AR, Maxwell BG, Minnier J, et al. Hospitalization trends and health resource use for adult congenital heart disease-related heart failure. J Am Heart Assoc. 2018;7(15):e008775.

    Article  PubMed  PubMed Central  Google Scholar 

  209. Stefanescu Schmidt AC, DeFaria YD, Tabtabai S, Kennedy KF, Yeh RW, Bhatt AB. National Trends in hospitalizations of adults with tetralogy of Fallot. Am J Cardiol. 2016;118(6):906–11.

    Article  PubMed  PubMed Central  Google Scholar 

  210. Willems R, Werbrouck A, De Backer J, Annemans L. Real-world healthcare utilization in adult congenital heart disease: a systematic review of trends and ratios. Cardiol Young. 2019;29(5):553–63.

    Article  PubMed  Google Scholar 

  211. Gatzoulis MA, Clark AL, Cullen S, Newman CG, Redington AN. Right ventricular diastolic function 15 to 35 years after repair of tetralogy of Fallot. Restrictive physiology predicts superior exercise performance. Circulation. 1995;91(6):1775–81.

    Article  CAS  PubMed  Google Scholar 

  212. Babu-Narayan SV, Uebing A, Davlouros PA, Kemp M, Davidson S, Dimopoulos K, et al. Randomised trial of ramipril in repaired tetralogy of Fallot and pulmonary regurgitation: the APPROPRIATE study (Ace inhibitors for Potential PRevention Of the deleterious effects of Pulmonary Regurgitation In Adults with repaired TEtralogy of Fallot). Int J Cardiol. 2012;154(3):299–305.

    Article  PubMed  Google Scholar 

  213. Krupickova S, Li W, Cheang MH, Rigby ML, Uebing A, Davlouros P, et al. Ramipril and left ventricular diastolic function in stable patients with pulmonary regurgitation after repair of tetralogy of Fallot. Int J Cardiol. 2018;272:64–9.

    Article  PubMed  Google Scholar 

  214. Knauth AL, Gauvreau K, Powell AJ, Landzberg MJ, Walsh EP, Lock JE, et al. Ventricular size and function assessed by cardiac MRI predict major adverse clinical outcomes late after tetralogy of Fallot repair. Heart. 2008;94(2):211–6.

    Article  CAS  PubMed  Google Scholar 

  215. Baumgartner H, Bonhoeffer P, De Groot NM, de Haan F, Deanfield JE, Galie N, et al. ESC guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J. 2010;31(23):2915–57.

    Article  PubMed  Google Scholar 

  216. Mongeon FP, Ben Ali W, Khairy P, Bouhout I, Therrien J, Wald RM, et al. Pulmonary valve replacement for pulmonary regurgitation in adults with tetralogy of Fallot: a meta-analysis-a report for the writing committee of the 2019 update of the Canadian cardiovascular society guidelines for the Management of Adults with Congenital Heart Disease. Can J Cardiol. 2019;35(12):1772–83.

    Article  PubMed  Google Scholar 

  217. Adamson GT, McElhinney DB, Lui G, Meadows AK, Rigdon J, Hanley FL, et al. Secondary repair of incompetent pulmonary valves after previous surgery or intervention: patient selection and outcomes. J Thorac Cardiovasc Surg. 2020;159(6):2383–92 e2.

    Article  PubMed  Google Scholar 

  218. Bokma JP, Geva T, Sleeper LA, Babu Narayan SV, Wald R, Hickey K, et al. A propensity score-adjusted analysis of clinical outcomes after pulmonary valve replacement in tetralogy of Fallot. Heart. 2018;104(9):738–44.

    Article  PubMed  Google Scholar 

  219. Tobler D, Crean AM, Redington AN, Van Arsdell GS, Caldarone CA, Nanthakumar K, et al. The left heart after pulmonary valve replacement in adults late after tetralogy of Fallot repair. Int J Cardiol. 2012;160(3):165–70.

    Article  PubMed  Google Scholar 

  220. Roos-Hesselink J, Perlroth MG, McGhie J, Spitaels S. Atrial arrhythmias in adults after repair of tetralogy of Fallot. Correlations with clinical, exercise, and echocardiographic findings. Circulation. 1995;91(8):2214–9.

    Article  CAS  PubMed  Google Scholar 

  221. Khairy P, Aboulhosn J, Gurvitz MZ, Opotowsky AR, Mongeon FP, Kay J, et al. Arrhythmia burden in adults with surgically repaired tetralogy of Fallot: a multi-institutional study. Circulation. 2010;122(9):868–75.

    Article  PubMed  Google Scholar 

  222. Egbe AC, Vallabhajosyula S, Vojjini R, Banala K, Najam M, Faizee F, et al. Prevalence and in-hospital mortality during arrhythmia-related admissions in adults with tetralogy of Fallot. Int J Cardiol. 2019;297:49–54.

    Article  PubMed  Google Scholar 

  223. Villafane J, Feinstein JA, Jenkins KJ, Vincent RN, Walsh EP, Dubin AM, et al. Hot topics in tetralogy of Fallot. J Am Coll Cardiol. 2013;62(23):2155–66.

    Article  PubMed  Google Scholar 

  224. Gatzoulis MA, Till JA, Somerville J, Redington AN. Mechanoelectrical interaction in tetralogy of Fallot. QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death. Circulation. 1995;92(2):231–7.

    Article  CAS  PubMed  Google Scholar 

  225. Khairy P, Harris L, Landzberg MJ, Viswanathan S, Barlow A, Gatzoulis MA, et al. Implantable cardioverter-defibrillators in tetralogy of Fallot. Circulation. 2008;117(3):363–70.

    Article  PubMed  Google Scholar 

  226. Mongeon FP, Gurvitz MZ, Broberg CS, Aboulhosn J, Opotowsky AR, Kay JD, et al. Aortic root dilatation in adults with surgically repaired tetralogy of fallot: a multicenter cross-sectional study. Circulation. 2013;127(2):172–9.

    Article  PubMed  Google Scholar 

  227. Egbe AC, Miranda WR, Ammash NM, Anavekar NS, Missula VR, Kothapalli S, et al. Aortic disease and interventions in adults with tetralogy of Fallot. Heart. 2019;105(12):926–31.

    PubMed  Google Scholar 

  228. Kay WA, Cook SC, Daniels CJ. Evaluation by MRA of aortic dilation late after repair of tetralogy of Fallot. Int J Cardiol. 2013;167(6):2922–7.

    Article  PubMed  Google Scholar 

  229. Rathi VK, Doyle M, Williams RB, Yamrozik J, Shannon RP, Biederman RW. Massive aortic aneurysm and dissection in repaired tetralogy of Fallot; diagnosis by cardiovascular magnetic resonance imaging. Int J Cardiol. 2005;101(1):169–70.

    Article  PubMed  Google Scholar 

  230. Kim WH, Seo JW, Kim SJ, Song J, Lee J, Na CY. Aortic dissection late after repair of tetralogy of Fallot. Int J Cardiol. 2005;101(3):515–6.

    Article  PubMed  Google Scholar 

  231. Konstantinov IE, Fricke TA, d’Udekem Y, Robertson T. Aortic dissection and rupture in adolescents after tetralogy of Fallot repair. J Thorac Cardiovasc Surg. 2010;140(5):e71–3.

    Article  PubMed  Google Scholar 

  232. Wijesekera VA, Kiess MC, Grewal J, Chow R, Raju R, Leipsic JA, et al. Aortic dissection in a patient with a dilated aortic root following tetralogy of Fallot repair. Int J Cardiol. 2014;174(3):833–4.

    Article  PubMed  Google Scholar 

  233. Ribeiro JM, Teixeira R, Lopes J, Costa M, Pires A, Goncalves L. Transcatheter versus surgical pulmonary valve replacement: a systemic review and meta-analysis. Ann Thorac Surg. 2020;110(5):1751–61.

    Article  PubMed  Google Scholar 

  234. Benson LN, Gillespie MJ, Bergersen L, Cheatham SL, Hor KN, Horlick EM, et al. Three-year outcomes from the harmony native outflow tract early feasibility study. Circ Cardiovasc Interv. 2020;13(1):e008320.

    Article  PubMed  Google Scholar 

  235. Kapel GF, Sacher F, Dekkers OM, Watanabe M, Blom NA, Thambo JB, et al. Arrhythmogenic anatomical isthmuses identified by electroanatomical mapping are the substrate for ventricular tachycardia in repaired Tetralogy of Fallot. Eur Heart J. 2017;38(4):268–76.

    PubMed  Google Scholar 

  236. Chen CA, Dusenbery SM, Valente AM, Powell AJ, Geva T. Myocardial ECV fraction assessed by CMR is associated with type of hemodynamic load and arrhythmia in repaired tetralogy of Fallot. JACC Cardiovasc Imaging. 2016;9(1):1–10.

    Article  CAS  PubMed  Google Scholar 

  237. Broberg CS, Huang J, Hogberg I, McLarry J, Woods P, Burchill LJ, et al. Diffuse LV myocardial fibrosis and its clinical associations in adults with repaired tetralogy of Fallot. JACC Cardiovasc Imaging. 2016;9(1):86–7.

    Article  PubMed  Google Scholar 

  238. Friedberg MK, Redington AN. Right versus left ventricular failure: differences, similarities, and interactions. Circulation. 2014;129(9):1033–44.

    Article  PubMed  Google Scholar 

  239. Zile MR, Gregg D. Is biventricular fibrosis the mediator of late complications in tetralogy of Fallot? JACC Cardiovasc Imaging. 2016;9(1):11–3.

    Article  PubMed  Google Scholar 

  240. Belli E, Serraf A, Lacour-Gayet F, Prodan S, Piot D, Losay J, et al. Biventricular repair for double-outlet right ventricle. Results and long-term follow-up. Circulation. 1998;98(19 Suppl):II360-5; discussion II5-7

    PubMed  Google Scholar 

  241. Bradley TJ, Karamlou T, Kulik A, Mitrovic B, Vigneswaran T, Jaffer S, et al. Determinants of repair type, reintervention, and mortality in 393 children with double-outlet right ventricle. J Thorac Cardiovasc Surg. 2007;134(4):967–73 e6.

    Article  PubMed  Google Scholar 

  242. Brown JW, Ruzmetov M, Okada Y, Vijay P, Turrentine MW. Surgical results in patients with double outlet right ventricle: a 20-year experience. Ann Thorac Surg. 2001;72(5):1630–5.

    Article  CAS  PubMed  Google Scholar 

  243. Kreutzer C, De Vive J, Oppido G, Kreutzer J, Gauvreau K, Freed M, et al. Twenty-five-year experience with rastelli repair for transposition of the great arteries. J Thorac Cardiovasc Surg. 2000;120(2):211–23.

    Article  CAS  PubMed  Google Scholar 

  244. Oladunjoye O, Piekarski B, Baird C, Banka P, Marx G, Del Nido PJ, et al. Repair of double outlet right ventricle: midterm outcomes. J Thorac Cardiovasc Surg. 2019;159(1):254–64.

    Article  PubMed  Google Scholar 

  245. Brothers JA, Frommelt MA, Jaquiss RDB, Myerburg RJ, Fraser CD Jr, Tweddell JS. Expert consensus guidelines: anomalous aortic origin of a coronary artery. J Thorac Cardiovasc Surg. 2017;153(6):1440–57.

    Article  PubMed  Google Scholar 

  246. Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO. Sudden deaths in young competitive athletes analysis of 1866 deaths in the United States, 1980-2006. Circulation. 2009;119:1085–92.

    Article  PubMed  Google Scholar 

  247. Eckart RE, Scoville SL, Campbell CL, Shry EA, Stajduhar KC, Potter RN, et al. Sudden death in young adults: a 25-year review of autopsies in military recruits. Ann Intern Med. 2004;141:829–34.

    Article  PubMed  Google Scholar 

  248. Van Hare GF, Ackerman MJ, Evangelista JAK, Kovacs RJ, Myerburg RJ, Shafer KM, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 4: congenital heart disease: a scientific statement from the American Heart Association and American College of Cardiology. Circulation. 2015;132:e281–91.

    PubMed  Google Scholar 

  249. Wesselhoeft H, Fawcett JS, Johnson AL. Anomalous origin of the left coronary artery from the pulmonary trunk. Its clinical spectrum, pathology, and pathophysiology, based on a review of 140 cases with seven further cases. Circulation. 1968;38(2):403–25.

    Article  CAS  PubMed  Google Scholar 

  250. Dodge-Khatami A, Mavroudis C, Backer CL. Anomalous origin of the left coronary artery from the pulmonary artery: collective review of surgical therapy. Ann Thorac Surg. 2002;74(3):946–55.

    Article  PubMed  Google Scholar 

  251. Peña E, Nguyen ET, Merchant N, Dennie C. ALCAPA syndrome: not just a pediatric disease. Radiographics. 2009;29:553–65.

    Article  PubMed  Google Scholar 

  252. Williams IA, Gersony WM, Hellenbrand WE. Anomalous right coronary artery arising from the pulmonary artery: a report of 7 cases and a review of the literature. Am Heart J. 2006;152(1004):e9–17.

    Google Scholar 

  253. Mongé MC, Eltayeb O, Costello JM, Sarwark AE, Carr MR, Backer CL. Aortic implantation of anomalous origin of the left coronary artery from the pulmonary artery: long-term outcomes. Ann Thorac Surg. 2015;100:154–61.

    Article  PubMed  Google Scholar 

  254. Lange R, Cleuziou J, Krane M, Ewert P, Pabst von Ohain J, Beran E, et al. Long-term outcome after anomalous left coronary artery from the pulmonary artery repair: a 40-year single-centre experience. Eur J Cardiothorac Surg. 2017;0:1–8.

    Google Scholar 

  255. Fehrenbacher TA, Mitchell ME, Ghanayem NS, Tweddell JS. Surgery and critical care for anomalous coronary artery from the pulmonary artery. Cardiol Young. 2010;20(Suppl 3):35–43.

    Article  PubMed  Google Scholar 

  256. Cheezum MK, Liberthson RR, Shah NR, Villines TC, O’Gara PT, Landzberg MJ, et al. Anomalous aortic origin of a coronary artery from the inappropriate sinus of Valsalva. J Am Coll Cardiol. 2017;69(12):1592–608.

    Article  PubMed  Google Scholar 

  257. Opolski MP, Pregowski J, Kruk M, Witkowski A, Kwiecinska S, Lubienska E, et al. Prevalence and characteristics of coronary anomalies originating from the opposite sinus of valsalva in 8,522 patients referred for coronary computed tomography angiography. Am J Cardiol. 2013;111:1361–7.

    Article  PubMed  Google Scholar 

  258. Frommelt P, Lopez L, Dimas VV, Eidem B, Han BK, Ko HH, et al. Recommendations for Multimodality Assessment of Congenital Coronary Anomalies: A Guide from the American Society of Echocardiography: Developed in Collaboration with the Society for Cardiovascular Angiography and Interventions, Japanese Society of Echocardiography, and Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr. 2020;33:259–94.

    Article  PubMed  Google Scholar 

  259. Said SM, Burkhart HM, Schaff HV, Connolly HM, Phillips SD, Suri RM, et al. Late outcome of repair of congenital coronary artery fistulas – a word of caution. J Thorac Cardiovasc Surg. 2013;145:455–60.

    Article  PubMed  Google Scholar 

  260. Fontan F, Baudet E. Surgical repair of tricuspid atresia. Thorax. 1971;26(3):240–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  261. Pundi KN, Johnson JN, Dearani JA, Pundi KN, Zhuo L, Hinck CA, et al. 40-year follow-up after the Fontan operation. J Am Coll Cardiol. 2015;66(15):1700–10.

    Article  PubMed  Google Scholar 

  262. Dennis M, Zannino D, du Plessis K, Bullock A, Disney PJS, Radford DJ, et al. Clinical outcomes in adolescents and adults after the Fontan procedure. J Am Coll Cardiol. 2018;71(9):1009–17.

    Article  PubMed  Google Scholar 

  263. Cohen MI, Wernovsky G, Vetter VL, Wieand TS, Gaynor JW, Jacobs ML, et al. Sinus node function after a systematically staged Fontan procedure. Circulation. 1998;98(19 Suppl):II352-8; discussion II8-9

    PubMed  Google Scholar 

  264. Gatzoulis MA, Munk MD, Williams WG, Webb GD. Definitive palliation with cavopulmonary or aortopulmonary shunts for adults with single ventricle physiology. Heart. 2000;83(1):51–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  265. Weipert J, Noebauer C, Schreiber C, Kostolny M, Zrenner B, Wacker A, et al. Occurrence and management of atrial arrhythmia after long-term Fontan circulation. J Thorac Cardiovasc Surg. 2004;127(2):457–64.

    Article  PubMed  Google Scholar 

  266. Stout KK, Daniels CJ, Aboulhosn JA, Bozkurt B, Broberg CS, Colman JM, et al. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139(14):e698–800.

    PubMed  Google Scholar 

  267. Paul Khairy M, Fernandes S, Mayer JE, Triedman JK, Walsh EP, Lock JE, et al. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation. 2008;117(1):85–92.

    Article  PubMed  Google Scholar 

  268. Mahnke CB, Boyle GJ, Janosky JE, Siewers RD, Pigula FA. Anticoagulation and incidence of late cerebrovascular accidents following the Fontan procedure. Pediatr Cardiol. 2005;26(1):56–61.

    Article  CAS  PubMed  Google Scholar 

  269. Yang H, Veldtman GR, Bouma BJ, Budts W, Niwa K, Meijboom F, et al. Non-vitamin K antagonist oral anticoagulants in adults with a Fontan circulation: are they safe. Open Heart. 2019;6(1):e000985.

    Article  PubMed  PubMed Central  Google Scholar 

  270. Aboulhosn J, Williams R, Shivkumar K, Barkowski R, Plunkett M, Miner P, et al. Arrhythmia recurrence in adult patients with single ventricle physiology following surgical Fontan conversion. Congenit Heart Dis. 2010;5(5):430–4.

    Article  PubMed  Google Scholar 

  271. Mavroudis C, Deal BJ, Backer CL, Stewart RD, Franklin WH, Tsao S, et al. J. Maxwell Chamberlain Memorial Paper for congenital heart surgery. 111 Fontan conversions with arrhythmia surgery: surgical lessons and outcomes. Ann Thorac Surg. 2007;84(5):1457–65; discussion 65-6.

    Article  PubMed  Google Scholar 

  272. Takahashi K, Fynn-Thompson F, Cecchin F, Khairy P, del Nido P, Triedman JK. Clinical outcomes of Fontan conversion surgery with and without associated arrhythmia intervention. Int J Cardiol. 2009;137(3):260–6.

    Article  PubMed  Google Scholar 

  273. Pundi K, Pundi KN, Kamath PS, Cetta F, Li Z, Poterucha JT, et al. Liver disease in patients after the Fontan operation. Am J Cardiol. 2016;117(3):456–60.

    Article  PubMed  Google Scholar 

  274. Rychik J, Atz AM, Celermajer DS, Deal BJ, Gatzoulis MA, Gewillig MH, et al. Evaluation and Management of the Child and Adult with Fontan Circulation: a scientific statement from the American Heart Association. Circulation. 2019; https://doi.org/10.1161/CIR.0000000000000696.

  275. Daniels CJ, Bradley EA, Landzberg MJ, Aboulhosn J, Beekman RH 3rd, Book W, et al. Fontan-associated liver disease: proceedings from the American College of Cardiology Stakeholders Meeting, October 1 to 2, 2015, Washington DC. J Am Coll Cardiol. 2017;70(25):3173–94.

    Article  PubMed  Google Scholar 

  276. Munsterman ID, Duijnhouwer AL, Kendall TJ, Bronkhorst CM, Ronot M, van Wettere M, et al. The clinical spectrum of Fontan-associated liver disease: results from a prospective multimodality screening cohort. Eur Heart J. 2019;40(13):1057–68.

    Article  CAS  PubMed  Google Scholar 

  277. Surrey LF, Russo P, Rychik J, Goldberg DJ, Dodds K, O’Byrne ML, et al. Prevalence and characterization of fibrosis in surveillance liver biopsies of patients with Fontan circulation. Hum Pathol. 2016;57:106–15.

    Article  PubMed  Google Scholar 

  278. Evans WN, Acherman RJ, Ciccolo ML, Carrillo SA, Galindo A, Rothman A, et al. MELD-XI scores correlate with post-Fontan hepatic biopsy fibrosis scores. Pediatr Cardiol. 2016;37(7):1274–7.

    Article  PubMed  Google Scholar 

  279. Elder RW, McCabe NM, Hebson C, Veledar E, Romero R, Ford RM, et al. Features of portal hypertension are associated with major adverse events in Fontan patients: the VAST study. Int J Cardiol. 2013;168(4):3764–9.

    Article  PubMed  PubMed Central  Google Scholar 

  280. Silva-Sepulveda JA, Fonseca Y, Vodkin I, Vaughn G, Newbury R, Vavinskaya V, et al. Evaluation of Fontan liver disease: correlation of transjugular liver biopsy with magnetic resonance and hemodynamics. Congenit Heart Dis. 2019;14(4):600–8.

    Article  PubMed  Google Scholar 

  281. Goldberg DJ, Surrey LF, Glatz AC, Dodds K, O’Byrne ML, Lin HC, et al. Hepatic fibrosis is universal following Fontan operation, and severity is associated with time from surgery: a liver biopsy and hemodynamic study. J Am Heart Assoc. 2017;6(5):e004809.

    Article  PubMed  PubMed Central  Google Scholar 

  282. Juliet Emamaullee N, Zaidi A, Schiano T, Jeffrey Kahn L, Valentino P, Hofer RE, et al. Fontan-associated liver disease. Circulation. 2020;142(6):591–604.

    Article  PubMed  PubMed Central  Google Scholar 

  283. Lewis MJ, Hecht E, Ginns J, Benton J, Prince M, Rosenbaum MS. Serial cardiac MRIs in adult Fontan patients detect progressive hepatic enlargement and congestion. Congenit Heart Dis. 2017;12(2):153–8.

    Article  PubMed  Google Scholar 

  284. Kuwabara M, Niwa K, Toyoda T, Shirai T, Tateno S, Ohuchi H, et al. Liver cirrhosis and/or hepatocellular carcinoma occurring late after the Fontan procedure- a Nationwide survey in Japan. Circ J. 2018;82(4):1155–60.

    Article  PubMed  Google Scholar 

  285. Possner M, Gordon-Walker T, Egbe AC, Poterucha JT, Warnes CA, Connolly HM, et al. Hepatocellular carcinoma and the Fontan circulation: clinical presentation and outcomes. Int J Cardiol. 2020;322:142–8.

    Article  PubMed  Google Scholar 

  286. Rychik J. Protein-losing enteropathy after Fontan operation. Congenit Heart Dis. 2007;2(5):288–300.

    Article  PubMed  Google Scholar 

  287. Schumacher KR, Singh TP, Kuebler J, Aprile K, O’Brien M, Blume ED. Risk factors and outcome of Fontan-associated plastic bronchitis: a case-control study. J Am Heart Assoc. 2014;3(2):e000865.

    Article  PubMed  PubMed Central  Google Scholar 

  288. Caruthers RL, Kempa M, Loo A, Gulbransen E, Kelly E, Erickson SR, et al. Demographic characteristics and estimated prevalence of Fontan-associated plastic bronchitis. Pediatr Cardiol. 2013;34(2):256–61.

    Article  PubMed  Google Scholar 

  289. John AS, Johnson JA, Khan M, Driscoll DJ, Warnes CA, Cetta F. Clinical outcomes and improved survival in patients with protein-losing enteropathy after the Fontan operation. J Am Coll Cardiol. 2014;64(1):54–62.

    Article  PubMed  Google Scholar 

  290. Davies RR, Sorabella RA, Yang J, Mosca RS, Chen JM, Quaegebeur JM. Outcomes after transplantation for "failed" Fontan: a single-institution experience. J Thorac Cardiovasc Surg. 2012;143(5):1183–92 e4.

    Article  PubMed  Google Scholar 

  291. Gamba A, Merlo M, Fiocchi R, Terzi A, Mammana C, Sebastiani R, et al. Heart transplantation in patients with previous Fontan operations. J Thorac Cardiovasc Surg. 2004;127(2):555–62.

    Article  PubMed  Google Scholar 

  292. Murtuza B, Hermuzi A, Crossland DS, Parry G, Lord S, Hudson M, et al. Impact of mode of failure and end-organ dysfunction on the survival of adult Fontan patients undergoing cardiac transplantation. Eur J Cardiothorac Surg. 2017;51(1):135–41.

    Article  PubMed  Google Scholar 

  293. Vaikunth SS, Concepcion W, Daugherty T, Fowler M, Lutchman G, Maeda K, et al. Short-term outcomes of en bloc combined heart and liver transplantation in the failing Fontan. Clin Transpl. 2019;33(6):e13540.

    Article  Google Scholar 

  294. Lewis MJ, Reardon L, Aboulhosn JA, Haeffele C, Chen S, Kim Y, et al. Morbidity and mortality in adult Fontan patients after heart or combined heart liver transplant: a report from the foster study. J Am Coll Cardiol. 2020;75(11):653.

    Article  Google Scholar 

  295. Moons P, Bovijn L, Budts W, Belmans A, Gewillig M. Temporal trends in survival to adulthood among patients born with congenital heart disease from 1970 to 1992 in Belgium. Circulation. 2010;122(22):2264–72.

    Article  PubMed  Google Scholar 

  296. Van Der Bom T, Bouma BJ, Meijboom FJ, Zwinderman AH, Mulder BJM. The prevalence of adult congenital heart disease, results from a systematic review and evidence based calculation. Am Heart J. 2012;164(4):568–75.

    Article  PubMed  Google Scholar 

  297. Bhatt AB, Foster E, Kuehl K, Alpert J, Brabeck S, Crumb S, et al. Congenital heart disease in the older adult. Circulation. 2015;131(21):1884–931.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Divisions of Cardiovascular Medicine and Pediatric Cardiology, Stanford University School of Medicine, Stanford, CA, USA

    Christiane Haeffele, Michael Bykhovsky, Sumeet Vaikunth & George K. Lui

Authors
  1. Christiane Haeffele
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael Bykhovsky
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sumeet Vaikunth
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. George K. Lui
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to George K. Lui .

Editor information

Editors and Affiliations

  1. Lurie Children's Hospital, Northwestern Memorial Hospital, Chicago, IL, USA

    Ra-id Abdulla

  2. Lurie Children's Hospital of Chicago, Northwestern Memorial Hospital, Chicago, USA

    Stuart Berger

  3. Lurie Children's Hospital of Chicago, Northwestern Memorial Hospital, Chicago, USA

    Carl Backer

  4. King's College, University College London, London, UK

    Robert Anderson

  5. Weill Cornell Medical College, Cornell University, New York, USA

    Ralf Holzer

  6. University of Amsterdam, Amsterdam, Noord-Holland, The Netherlands

    Nico Blom

  7. Lurie Children's Hospital of Chicago, Northwestern Memorial Hospital, Chicago, IL, USA

    Joshua Robinson

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Haeffele, C., Bykhovsky, M., Vaikunth, S., Lui, G.K. (2023). Long Term Follow Up of Adults with Congenital Heart Disease. In: Abdulla, Ri., et al. Pediatric Cardiology. Springer, Cham. https://doi.org/10.1007/978-3-030-42937-9_97-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-42937-9_97-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-42937-9

  • Online ISBN: 978-3-030-42937-9

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation